Stimulator, Bone Growth, Non-Invasive
Basic Information
- Device Name
- Stimulator, Bone Growth, Non-Invasive
- Trade Name
- BIOMET ORTHOPAK NON-INVASIVE BONE STIMULATOR SYSTEM & BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM
- PMA Number
- P850022
- Supplement Number
- S018
- Device Class
- FDA Class 3
- Product Code
- LOF
- Generic Name
- Stimulator, bone growth, non-invasive
- Medical Specialty
- Unknown
- Advisory Committee
- Orthopedic
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- August 11, 2011
- Date Received
- June 13, 2011
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
APPROVAL FOR THE MODIFICATION OF THE SYSTEM SOFTWARE TO INCLUDE AN ADDITIONAL LINE OF CODE WHICH WOULD ALLOW THE REAL-TIME CLOCK TO RESET TO 'DAY ZERO' AFTER AN ELAPSED 365 DAYS, THIS RESET WOULD ALLOW YOUR DEVICE TO REMAIN FUNCTIONAL AFTER 365 DAYS OF INACTIVITY. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAMES ORTHOPAK NON-INVASIVE BONE GROWTH STIMULATOR SYSTEM AND SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM AND ARE INDICATED FOR THE FOLLOWING: 1) THE BIOMET ORTHOPAK NON-INVASIVE BONE GROWTH STIMULATOR SYSTEM IS INDICATED FOR THE TREATMENT OF AN ESTABLISHED NONUNION ACQUIRED SECONDARY TO TRAUMA, EXCLUDING VERTEBRAE AND ALL FLAT BONES, WHERE THE WIDTH OF THE NONUNION DEFECT IS LESS THAN ONE-HALF THE WIDTH OF THE BONE TO BE TREATED. A NONUNION IS CONSIDERED TO BE ESTABLISHED WHEN THE FRACTURE SITE SHOWS NO VISIBLE PROGRESSIVE SIGNS OF HEALING; AND 2) THE BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM IS INDICATED AS AN ADJUNCT ELECTRICAL TREATMENT TO PRIMARY LUMBAR SPINAL FUSION SURGERY FOR ONE OR TWO LEVELS.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LOF | Stimulator, Bone Growth, Non-Invasive | FDA class 3 | Unknown |